Acute Arterial Occlusion Following ChAdOx1 nCov-19 (Oxford–AstraZeneca) Vaccination
Sign Up to like & getrecommendations! Published in 2022 at "Cardiovascular and Interventional Radiology"
DOI: 10.1007/s00270-021-03053-3
Abstract: To the Editor, there have been documented cases of rare thrombotic events associated with venous thrombosis and thrombocytopenia post vaccination with ChAdOx1 nCov19 (Oxford-AstraZeneca COVID-19 Vaccine). This phenomenon was termed vaccine-induced immune thrombotic thrombocytopenia (VIITT)… read more here.
Keywords: chadox1 ncov; vaccination; oxford astrazeneca; acute arterial ... See more keywords
Minimal Change Disease With Severe Acute Kidney Injury Following the Oxford-AstraZeneca COVID-19 Vaccine: A Case Report
Sign Up to like & getrecommendations! Published in 2021 at "American Journal of Kidney Diseases"
DOI: 10.1053/j.ajkd.2021.06.008
Abstract: We report a CASE of minimal change disease (MCD) with severe acute kidney injury (AKI) following the first injection of the ChAdOx1 nCoV-19/AZD1222 vaccine (Oxford-AstraZeneca). A 71-year-old man with history of dyslipidemia and a baseline… read more here.
Keywords: change disease; oxford astrazeneca; case; vaccine ... See more keywords
Acute onset ocular myasthenia gravis after vaccination with the Oxford-AstraZeneca COVID-19 vaccine.
Sign Up to like & getrecommendations! Published in 2022 at "Orbit"
DOI: 10.1080/01676830.2022.2062777
Abstract: Myasthenia gravis (MG) is an autoimmune disease that results in muscle weakness and fatigability. Extraocular involvement may be the first sign of disease. It may be triggered by infections, stress, or medications. We describe a… read more here.
Keywords: oxford astrazeneca; covid; myasthenia gravis; covid vaccine ... See more keywords
Thrombosis with thrombocytopenia after vaccination with the ChAdOx1 nCoV-19 vaccine (Oxford–AstraZeneca): implications of gender-specific tissue-factor gene polymorphisms?
Sign Up to like & getrecommendations! Published in 2022 at "Expert Review of Clinical Pharmacology"
DOI: 10.1080/17512433.2023.2154650
Abstract: A number of cases of unusual thrombotic events connected with thrombocytopenia and particularly severe clinical courses have been reported after vaccination with the recombinant adenoviral vector encoding the spike protein antigen of severe acute respiratory… read more here.
Keywords: thrombosis; thrombocytopenia; vaccine; oxford astrazeneca ... See more keywords
An Analysis of Serological Response and Infection Outcomes Following Oxford-AstraZeneca (AZD1222) and Pfizer-BioNTech (mRNA BNT162b2) SARS-CoV-2 Vaccines in Kidney and Kidney-pancreas Transplants
Sign Up to like & getrecommendations! Published in 2022 at "Transplantation"
DOI: 10.1097/tp.0000000000004105
Abstract: Background. Severe acute respiratory syndrome coronavirus 2 is associated with high mortality among transplant recipients. Comparative data that define humoral responses to the Oxford-AstraZeneca (AZ) and BNT162b2 (Pfizer-BioNTech) vaccines are limited. Methods. We recruited 920… read more here.
Keywords: bnt162b2; pfizer; oxford astrazeneca; pfizer biontech ... See more keywords
Response to "A case of de novo generalised pustular psoriasis following Oxford-AstraZeneca COVID-19 Vaccine": Possible role for Type I interferons.
Sign Up to like & getrecommendations! Published in 2021 at "Clinical and experimental dermatology"
DOI: 10.1111/ced.14941
Abstract: We read with interest the article entitled "A case of de novo generalised pustular psoriasis following Oxford-AstraZeneca COVID-19 Vaccine" by Elamin et al.1 The authors describe a 66-year-old woman who developed new-onset generalised pustular psoriasis… read more here.
Keywords: covid vaccine; oxford astrazeneca; astrazeneca covid; generalised pustular ... See more keywords
"Pityriasis Rosea-like cutaneous eruption as a possible dermatological manifestation after Oxford-AstraZeneca vaccine: case report and brief literature review."
Sign Up to like & getrecommendations! Published in 2021 at "Dermatologic therapy"
DOI: 10.1111/dth.15129
Abstract: Pityriasis Rosea (PR) has been manifested in patients suffering from COVID-19 as well as after vaccine protocols against SARS-CoV-2. It has a possible association with the HHV-6B virus (roseola infantum) and can be controlled by… read more here.
Keywords: oxford; oxford astrazeneca; astrazeneca vaccine; brief literature ... See more keywords
COVID vaccine‐induced pustular psoriasis in patients with previous plaque type psoriasis
Sign Up to like & getrecommendations! Published in 2022 at "Journal of the European Academy of Dermatology and Venereology"
DOI: 10.1111/jdv.17918
Abstract: tions have been reported following Oxford–AstraZeneca vaccination. Based on these findings, we hypothesize that delayed-type hypersensitivity reaction associated with polysorbate 80 can contribute to the occurrence of Wells’ syndrome. Further studies involving patch test for… read more here.
Keywords: covid vaccine; psoriasis; oxford astrazeneca; vaccine induced ... See more keywords
Who funded the research behind the Oxford–AstraZeneca COVID-19 vaccine?
Sign Up to like & getrecommendations! Published in 2021 at "BMJ Global Health"
DOI: 10.1136/bmjgh-2021-007321
Abstract: Objectives The Oxford–AstraZeneca COVID-19 vaccine (ChAdOx1 nCoV-19, Vaxzevira or Covishield) builds on two decades of research and development (R&D) into chimpanzee adenovirus-vectored vaccine (ChAdOx) technology at the University of Oxford. This study aimed to approximate… read more here.
Keywords: oxford astrazeneca; chadox; astrazeneca covid; funding ... See more keywords
Branch retinal vein occlusion following ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine.
Sign Up to like & getrecommendations! Published in 2022 at "European journal of ophthalmology"
DOI: 10.1177/11206721221124651
Abstract: PURPOSE To present a case of branch retinal vein occlusion (BRVO) following ChAdOx1 nCoV-19 (Oxford-AstraZeneca) Vaccine. METHODS Case report. RESULTS A 60-year old otherwise healthy Caucasian male, presented to the ophthalmology emergency clinic complaining of… read more here.
Keywords: ophthalmology; oxford astrazeneca; astrazeneca vaccine; branch retinal ... See more keywords
Effectiveness of the BNT162b2 (Pfizer-BioNTech) and the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccines for reducing susceptibility to infection with the Delta variant (B.1.617.2) of SARS-CoV-2
Sign Up to like & getrecommendations! Published in 2022 at "BMC Infectious Diseases"
DOI: 10.1186/s12879-022-07239-z
Abstract: Background From January to May 2021 the alpha variant (B.1.1.7) of SARS-CoV-2 was the most commonly detected variant in the UK. Following this, the Delta variant (B.1.617.2) then became the predominant variant. The UK COVID-19… read more here.
Keywords: sars cov; delta variant; oxford astrazeneca; infection ... See more keywords